ArticleMolecular therapy. Nucleic acids2025

Targeting rare splicing defects: Antisense oligonucleotides offer a therapeutic strategy in FRDA.

Laurie M C Kerkhof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.